earnings
confidence high
sentiment neutral
materiality 0.70
Chemed Q1 revenue up 9.8% to $646.9M; GAAP EPS $4.86, adjusted $5.63
CHEMED CORP
2025-Q1 EPS reported
$4.86
revenue$646,943,000
- VITAS net revenue +15.1% to $407.4M; ADC 22,244 (+13.1%); adjusted EBITDA $70.3M (+15.9%).
- Roto-Rooter revenue +1.8% to $239.5M but adjusted EBITDA -2.4% to $59.2M; margin down 108 bps.
- Cash $173.9M; no debt; repurchased 50k shares for $29.8M at $595.15/share.
- Covenant Health contributed ~$12M revenue, $2.6M EBITDA in Q1.
- Full-year guidance update deferred to Q2 earnings release in June.